Home » Topics » Regulatory

Regulatory
RSS

FDA grants marketing approval to Acorda's Ampyra to improve walking in MS patients

Jan. 25, 2010

Daiichi granted Japanese approval to manufacture and market Rezaltas for hypertension

Jan. 21, 2010

Shionogi receives marketing approval for peramivir in Japan

Jan. 15, 2010

BioMarin's amifampridine phosphate approved in the EU for LEMS

Jan. 7, 2010

Novartis' Onbrez Breezhaler approved in E.U. for patients with COPD

Dec. 4, 2009

Kalbitor approved in U.S. for hereditary angioedema

Dec. 3, 2009

FDA approves Cymbalta for maintenance treatment of GAD

Dec. 1, 2009

Angiox approved in E.U. for additional indication

Dec. 1, 2009

France grants marketing authorization to Sanofi's Panenza influenza vaccine

Nov. 18, 2009

FDA approves Lysteda for the treatment of menorrhagia

Nov. 17, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...